Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells|
|Citation:||Proceedings of the National Academy of Sciences of the United States of America, 2007; 104(34):13762-13767|
|Publisher:||Natl Acad Sciences|
|Yvette Drabsch, Honor Hugo, Rui Zhang, Dennis H. Dowhan, Yu Rebecca Miao, Alan M. Gewirtz, Simon C. Barry, Robert G. Ramsay, and Thomas J. Gonda|
|Abstract:||MYB (the human ortholog of c-myb) is expressed in a high proportion of human breast tumors, and that expression correlates strongly with estrogen receptor (ER) positivity. This may reflect the fact that MYB is a target of estrogen/ER signaling. Because in many cases MYB expression appears to be regulated by transcriptional attenuation or pausing in the first intron, we first investigated whether this mechanism was involved in estrogen/ER modulation of MYB. We found that this was the case and that estrogen acted directly to relieve attenuation due to sequences within the first intron, specifically, a region potentially capable of forming a stem–loop structure in the transcript and an adjacent poly(dT) tract. Secondly, given the involvement of MYB in hematopoietic and colon tumors, we also asked whether MYB was required for the proliferation of breast cancer cells. We found that proliferation of ER+ but not ER- breast cancer cell lines was inhibited when MYB expression was suppressed by using either antisense oligonucleotides or RNA interference. Our results show that MYB is an effector of estrogen/ER signaling and provide demonstration of a functional role of MYB in breast cancer.|
|Keywords:||transcriptional attenuation; cell cycle; proliferation; antisense; short hairpin RNA|
|Description:||Copyright © 2007 by the National Academy of Sciences|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.